Jennifer Plair, PharmD, MSPH Executive Fellow, NC Association of Pharmacists
Learning Objectives:
Identify new medications that have recently been FDA-approved
Describe the indication, mechanisms of action, typical doses, common adverse reactions, and contraindications associated with these medications
Discuss monitoring parameters for these medications
Description: This presentation will provide information on 2023 FDA-approved drugs. These drugs provide new treatment options for patients and advances in healthcare for the American public. This will be a comprehensive review that will identify the new agents, describe the indication, the mechanism of action, and more. Explaining to patients how to maximize the products' therapeutic effects will also be discussed.
